Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs7016084 | chr8:121503583 | A/G | 4.11E-6 | 178 | 27.23 | 25 | 19.87 | KM Plot |
PCPG | rs7016677 | chr8:126223096 | A/C | 0.000275 | 178 | 25.77 | 25.53 | 4.17 | KM Plot |
PCPG | rs704464 | chr3:80675741 | A/G | 0.000161 | 178 | 27.27 | 23.48 | 19.87 | KM Plot |
PCPG | rs7044931 | chr9:36111917 | T/C | 0 | 178 | 25.47 | 24.5 | 2.93 | KM Plot |
PCPG | rs7045963 | chr9:136927728 | G/A | 5.12E-7 | 176 | 25.6 | 21.55 | 31.47 | KM Plot |
PCPG | rs7074999 | chr10:50602997 | G/A | 4.15E-6 | 177 | 24.52 | 33.13 | 25.17 | KM Plot |
PCPG | rs7078860 | chr10:131965392 | A/G | 0 | 178 | 25.53 | 24.47 | 3.17 | KM Plot |
PCPG | rs7082126 | chr10:131967508 | C/T | 0 | 178 | 25.4 | 25.33 | 3.17 | KM Plot |
PCPG | rs70937251 | chr2:114686707 | GT/G | 0.000292 | 171 | 25.53 | 23.43 | 3.17 | KM Plot |
PCPG | rs70961718 | chr2:241525858 | C/G | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs7096626 | chr10:101490870 | G/A | 9.93E-5 | 177 | 17.88 | 29.62 | 23.43 | KM Plot |
PCPG | rs71020572 | chr7:1111186 | AGGAGAGGGAGGAAAGG/GGGAGAGGGAGGAAAGG | 0.000233 | 176 | 25.87 | 24.5 | 49.58 | KM Plot |
PCPG | rs71043062 | chr2:229300723 | CT/C | 0 | 177 | 25.67 | 24.23 | 3.17 | KM Plot |
PCPG | rs71084466 | chr13:37647771 | C/CGT | 0.000355 | 176 | 4.17 | 19.1 | 25.97 | KM Plot |
PCPG | rs71115945 | chr14:74499919 | AT/A | 0.000293 | 177 | 25.4 | 28.3 | 10.3 | KM Plot |